Redoxis AB

Redoxis is a preclinical boutique CRO specializing on inflammation and autoimmune conditions. We provide in vivo, ex vivo and in vitro preclinical efficacy and MoA studies. We have a fully equipped lab with capacity to perform a wide range of cell based assays as well as immunology assays to provide you everything form MoA studies to PK and in vivo efficacy studies

Autoimmunity,immunology,cro,animal models,in vitro,cell based assays,3d cell culture,inflammation,preclinical,service,arthritis,multiple sclerosis,parkinsons disease,sepsis,in vivo,and boutique cro

Redoxis ab operates in the Research services industry.

Redoxis ab's revenue is 11m - 100m

Redoxis ab has 11 - 50 employees.